← Back to home

China Approves Bayer's Stroke Drug Asundexian, First in a New Class of Blood Thinners

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

China approved Bayer's asundexian for adults who have had certain…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home